BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
- Award
Common Stock
2017-03-06+35,885→ 35,885 total - Award
Stock Option (right to buy)
2017-03-06+47,847→ 47,847 totalExercise: $4.18From: 2017-03-06Exp: 2019-03-06→ Common Stock (47,847 underlying)
Footnotes (2)
- [F1]Shares acquired are shares of restricted stock awarded on March 6, 2017 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date.
- [F2]Option is fully vested and exercisable as of the date of grant and shall remain exercisable until the 2nd anniversary of the date of grant.